The company plans to stop selling its Imager II Angiographic Catheters after a manufacturing problem led the company to pull ...

The attack affected global operations, and its full scope is still being determined, the medical device maker said in a ...

Hospitals can use automated controllers in inventory while waiting for service from J&J’s Abiomed business to ensure patients ...

Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.

Building on its image-guided therapy platform, Philips will work with academic collaborators to create a robot capable of ...

Valerie Dixon arrives at Cleveland Diagnostics as the company works to commercialize its prostate cancer test in the U.S.

A U.S. court ruled Guardant willfully infringed two core patents for DNA sequencing methods in a case brought by TwinStrand ...

The attack has affected the company’s ability to manufacture products and to process and ship customers’ orders, and there is ...

Jonathan Pratt will take over the role on Sept. 1. The announcement ends Qiagen’s nearly 10-month search for a new chief ...

For the second time in two years, Medtronic has pulled capsules from the market over a fault that could obstruct patients’ ...

Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.

Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ...